Cite
HARVARD Citation
Staber, P. et al. (2021). Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor. Leukemia & lymphoma. 62 (14), pp. 3440-3451. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Staber, P. et al. (2021). Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor. Leukemia & lymphoma. 62 (14), pp. 3440-3451. [Online].